Transplants have the potential to lead to a more active and longer life, free from the limitations of routine dialysis and diet. However, the new kidney will need lifelong care and periodic re-examination, taking anti-rejection drugs regularly, at the right dose, at the right time as prescribed by the doctor to prevent transplant rejection, this is a common complication. and most importantly after kidney transplant.

Kidney transplant rejection is a phenomenon that can occur in people who do not comply with treatment, often skip doses of medication and forget to have regular health check-ups. Therefore, patients need to pay attention to these things to minimize the risk of transplant rejection.

New-onset inflammatory bowel disease after transplantation typically occurs late in the follow-up period, with a median delay of 91 months. Clinical manifestations of new-onset inflammatory bowel disease are similar to those occurring in the general population, including bloody diarrhea and abdominal pain.

Graft-versus-host disease in kidney transplant recipients is extremely rare. The pathogenesis of graft-versus-host disease is not fully understood, but it may be triggered by destruction of host tissues through a number of different mechanisms involving donor cytotoxic T cells.